MYX mayne pharma group limited

Cosette wouldn’t walk into litigation here lightly, even if its...

  1. 2 Posts.
    Cosette wouldn’t walk into litigation here lightly, even if its disclosures have been vague on quantifying how the MAC was breached. Pendal / Perpetual strictly speaking relates to liquidated damages as an insufficient surrogate for specific performance. The latter is totally distinguishable from Cosette’s concerns here. I would be anxious about Cosette’s claims regarding due diligence breaches; breaching Australian consumer law; and the very woolly EBITDA quantification, which is constructively vague for the bidder. You may find that the Supreme Court is unduly receptive; and remember that Judges love the opportunity to innovate. You may find the Judge (Black) will relish the chance to find a violated quantified MAC, since if nothing else it will be a novel result in Australian law. This isn’t Twitter 2.0; remember that Musk waived due diligence. This could be Fresenius 2.0, given Maybe’s terrible tendency in recent disclosures / rightful upbraiding by ASX since March.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.05
Change
0.020(0.40%)
Mkt cap ! $410.2M
Open High Low Value Volume
$5.04 $5.13 $4.98 $1.547M 305.6K

Buyers (Bids)

No. Vol. Price($)
1 1421 $4.98
 

Sellers (Offers)

Price($) Vol. No.
$5.16 322 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.